www.fdanews.com/articles/159719-mannkind-files-inhaled-insulin-product-with-fda-again
MannKind Files Inhaled Insulin Product With FDA Again
October 16, 2013
MannKind has submitted yet another application for its inhaled insulin drug Afrezza after positive results of Phase II trials.
Pharma Times
Pharma Times